Lipoproteins and Cardiovascular Health

76 ta ish

1. Influence of abnormal lipid components in statin-naive young adults: Is there any gap?

   Jamol Uzokov

   BoshqaLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology201910 iqtibos

   ABIABI:AkademIndex/2019.other.000001

2. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

   Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens +82

   MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthAtherosclerosis20182 iqtibos

   ABIABI:AkademIndex/2018.article.000004

3. Combination lipid lowering therapy with rosuvastatin and ezetimibe in dyslipidemic patients with stable coronary artery disease and metabolic syndrome

   Jamol Uzokov, B. A. Alyavi

   MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20182 iqtibos

   ABIABI:AkademIndex/2018.article.000349

4. Aspirin Resistance in Patients with Chronic Coronary Syndrome

   A. L. Alyavi, Sh.I.Khodjanova, Jamol Uzokov +1

   MaqolaOAOchiq kirishAntiplatelet Therapy and Cardiovascular DiseasesIndian Journal of Forensic Medicine & Toxicology20212 iqtibos

   ABIABI:AkademIndex/2021.article.002392

5. Influence of combination therapy of rosuvastatin and telmisartan on vascular and metabolic profile in hypercholesterolemic patients with metabolic syndrome

   Jamol Uzokov, Anis Alyavi, Baxrom Alyavi

   MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20171 iqtibos

   ABIABI:AkademIndex/2017.article.000354

6. Influence of high doses of atorvastatin on myocardial stanning in acute myocardial infarction

   Nizom Aziz, Sirojiddin Kenjaev, Majid Kenjaev

   MaqolaCardiac Imaging and DiagnosticsAtherosclerosis20171 iqtibos

   ABIABI:AkademIndex/2017.article.000368

7. TCTAP A-158 Short Term Outcomes After Coronary Artery Stenting in Patients with Metabolic Syndrome

   Jamol Uzokov, Anis Alyavi, Bakhrom Alyavi

   MaqolaOAOchiq kirishCoronary Interventions and DiagnosticsJournal of the American College of Cardiology20171 iqtibos

   ABIABI:AkademIndex/2017.article.000407

8. Efficiency and safety of rosuvastatin in patients with metabolic syndrome

   Anis Alyavi, Baxrom Alyavi, Jamol Uzokov

   MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20171 iqtibos

   ABIABI:AkademIndex/2017.article.000437

9. Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle

   Aleksandr B. Shek, Rano Alieva, R. D. Kurbanov +4

   MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20181 iqtibos

   ABIABI:AkademIndex/2018.article.000323

10. Influence of combined lipid lowering therapy on lipid components and interleukins in dyslipidemic patients with coronary artery disease after PCI

    Jamol Uzokov, Bakhromkhon Alyavi, A. Abdullaev

    MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20201 iqtibos

    ABIABI:AkademIndex/2020.article.000604

11. Statins and dementia: effect of statins beyond the treatment of dyslipidaemia

    Jamol Uzokov

    BoshqaOAOchiq kirishLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology20211 iqtibos

    ABIABI:AkademIndex/2021.other.000002

12. Risk Factors and Main Aspects of Lipid Metabolism Disturbances (Literary Review)

    Mavlonov Namoz Khalimovich, Tursunova Dilobar Erkinovna, Nurilloeva Shakhodat Nurillo Kizi +1

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthJournal Of Advanced Zoology20231 iqtibos

    ABIABI:AkademIndex/2023.article.002932

13. Advancements in risk stratification and management strategies in primary cardiovascular prevention

    Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush +25

    Sharh maqolaOAOchiq kirishLipoproteins and Cardiovascular HealthAtherosclerosis20241 iqtibos

    ABIABI:AkademIndex/2024.review-article.000004

14. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

    Amany Elshorbagy, Antonio J. Vallejo‐Vaz, Fotios Barkas +80

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthEuropean Heart Journal20251 iqtibos

    ABIABI:AkademIndex/2025.article.000498

15. MYOCARDIAL INFARCT IMAGING AFTER CARDIAC SURGERY*

    F Panetta, C. Wong, L. M. Dugdale +4

    MaqolaCardiac, Anesthesia and Surgical OutcomesAustralian and New Zealand Journal of Surgery19790 iqtibos

    ABIABI:AkademIndex/1979.article.000052

16. Revealing of Initial Factors Defining Results of Operation in Patients with Aortic Valve Replacement and Coronary Artery Disease

    Alexander Karaskov, Ф Ф Тураев, S.I. Jheleznev

    BobOAOchiq kirishCardiac Valve Diseases and TreatmentsInTech eBooks20110 iqtibos

    ABIABI:AkademIndex/2011.chapter.000019

17. Influence of Lipid Transport System Gene Polymorphism on the Dyslipidemia and Coronary Lesions in Patients with Unstable Angina

    A. S. Eshpulatov, Tashkent, Uzbekistan, Shavkat Hashimov +2

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthInternational Journal of Biomedicine20150 iqtibos

    ABIABI:AkademIndex/2015.article.000792

18. PERSONALIZED STATIN THERAPY IN IMPROVING THE TREATMENT OF CORONARY ARTERY DISEASE AND ATHEROSCLEROSIS

    Umidakhon Makhmudova, Sh. U. Hoshimov, G. J. Abdullayeva +2

    MaqolaOAOchiq kirishPharmacogenetics and Drug MetabolismEurasian heart journal20150 iqtibos

    ABIABI:AkademIndex/2015.article.000910

19. N-Acetylcysteine in a combination therapy reduces myocardial damage in patients with acute coronary syndrome and improves left ventricular function after percutaneous coronary intervention

    A. Nizomov, Bekzod Toshev, M.G. Mukhamedova +1

    MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20160 iqtibos

    ABIABI:AkademIndex/2016.article.000307

20. Incidence of valvular heart disease after combination of dopamin agonists with statins

    Elvina Giyazitdinova, Bakhrom Muinjonov, G. Rakhimbayeva +1

    MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20160 iqtibos

    ABIABI:AkademIndex/2016.article.000707

21. Changes in plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after atorvastatin

    Bakhrom Muinjonov, Elvina Giyazitdinova

    MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20160 iqtibos

    ABIABI:AkademIndex/2016.article.000722

22. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology

    Richard Češka, Tomáš Freiberger, Andrey V. Susekov +26

    MaqolaLipoproteins and Cardiovascular HealthVnitřní lékařství20170 iqtibos

    ABIABI:AkademIndex/2017.article.000199

23. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and Design

    Richard Češka, György Paragh, Željko Reiner +26

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthVnitřní lékařství20170 iqtibos

    ABIABI:AkademIndex/2017.article.000270

24. Effect of high-dose atorvastatin on lipid spectrum and inflammation in acute myocardial infarction

    A. Nizomov, Sirojiddin Kenjaev

    MaqolaCancer, Lipids, and MetabolismAtherosclerosis20170 iqtibos

    ABIABI:AkademIndex/2017.article.000688

25. AB0296 HMG-COA reductase inhibitor drugs (STATINS) benefit in cardiovascular risk prevention and ameliorate disease activity in patients with rheumatoid arthritis

    Alice Hon, M. J. Sultanova

    MaqolaOAOchiq kirishRheumatoid Arthritis Research and TherapiesAnnals of the Rheumatic Diseases20170 iqtibos

    ABIABI:AkademIndex/2017.article.000727